Weekly shot combo aims to shed pounds in major obesity trial
NCT ID NCT06862791
Summary
This study is testing whether two experimental drugs, AZD9550 and AZD6234, work better together or alone than a placebo for weight loss. About 360 adults with obesity or overweight who also have a related health condition will receive weekly injections for 36 weeks. The main goal is to see how much body weight participants lose and if the combination is more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY OR OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Dothan, Alabama, 36305, United States
-
Research Site
Vestavia Hills, Alabama, 35216, United States
-
Research Site
Cerritos, California, 90703, United States
-
Research Site
Escondido, California, 92025, United States
-
Research Site
Huntington Park, California, 90255, United States
-
Research Site
Lincoln, California, 95648, United States
-
Research Site
Sacramento, California, 95864, United States
-
Research Site
Waterbury, Connecticut, 06708, United States
-
Research Site
Palm Harbor, Florida, 34684, United States
-
Research Site
Decatur, Georgia, 30030, United States
-
Research Site
Stockbridge, Georgia, 30281, United States
-
Research Site
Champaign, Illinois, 61822, United States
-
Research Site
South Bend, Indiana, 46617, United States
-
Research Site
Valparaiso, Indiana, 46383, United States
-
Research Site
Sioux City, Iowa, 51106, United States
-
Research Site
Southfield, Michigan, 48034, United States
-
Research Site
Missoula, Montana, 59804, United States
-
Research Site
Omaha, Nebraska, 68114, United States
-
Research Site
Albuquerque, New Mexico, 87107, United States
-
Research Site
Fargo, North Dakota, 58104, United States
-
Research Site
Cincinnati, Ohio, 45219, United States
-
Research Site
Columbus, Ohio, 43213, United States
-
Research Site
Tulsa, Oklahoma, 74133, United States
-
Research Site
Medford, Oregon, 97504, United States
-
Research Site
Kingsport, Tennessee, 37660, United States
-
Research Site
Brownsville, Texas, 78526, United States
-
Research Site
Houston, Texas, 77043, United States
-
Research Site
Arlington, Virginia, 22206, United States
-
Research Site
Renton, Washington, 98057, United States
-
Research Site
Maroochydore, 4556, Australia
-
Research Site
Maroubra, 2035, Australia
-
Research Site
Norwood, 5067, Australia
-
Research Site
St Albans, 3021, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Calgary, Alberta, T2V 4J2, Canada
-
Research Site
Surrey, British Columbia, V3T 2V6, Canada
-
Research Site
Guelph, Ontario, N1G 0B4, Canada
-
Research Site
Hamilton, Ontario, L8J 0B6, Canada
-
Research Site
Hamilton, Ontario, L8L 5G8, Canada
-
Research Site
Sarnia, Ontario, N7T 4X3, Canada
-
Research Site
Stouffville, Ontario, L4A1H2, Canada
-
Research Site
Montreal, Quebec, H4N 2W2, Canada
-
Research Site
Berlin, 10787, Germany
-
Research Site
Essen, 45136, Germany
-
Research Site
Falkensee, 14612, Germany
-
Research Site
Hamburg, 22607, Germany
-
Research Site
Münster, 48145, Germany
-
Research Site
Oldenburg, 23758, Germany
-
Research Site
Chūōku, 103-0027, Japan
-
Research Site
Chūōku, 104-0031, Japan
-
Research Site
Fukuoka, 812-0025, Japan
-
Research Site
Shinjuku-ku, 160-0008, Japan
-
Research Site
Suita-shi, 565-0853, Japan
Conditions
Explore the condition pages connected to this study.